Rong Deng

Rong Deng

Auto-generated profile, based on publicly available information

Rong Deng

Department of General Surgery, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Baiziting 42, Nanjing 210009, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
LLLi Li
Li Li
DWDa Wei
Da Wei
JZJunying Zhang
Junying Zhang
RDRong Deng
Rong Deng
JTJinhai Tang
Jinhai Tang
DSDongming Su
Dongming Su
Objective. Studies revealed an important role of microRNAs (miRNAs) in multiple cancers, including breast cancer. In the present study, we evaluated the role and function of miR-641 in breast cancer. Methods. The expression level of miR-641 in breast cancer cell lines (Hs-578T, MCF7, HCC1937, and MAD-MB-231) was determined by real-time PCR. Functional analyses, including CCK-8 assay, transwell assay, wound-healing assay, and apoptosis detection, were carried out to explore the roles of miRNA-641 in malignant behaviors of breast cancer. Luciferase report assay was used to investigate the regulatory association of miRNA-641 with its potential targets. Results. The expression levels of miR-641 were downregulated, while the expression levels of nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1) were increased in breast cancer cell lines. The in vitro results showed that miR-641 repressed proliferation and migration/invasion and promoted apoptosis of breast cancer cells. NUCKS1, a positive regulator of phosphatidylinositol-3-kinases (PI3K)/protein-serine-threonine kinase (AKT) pathway, was confirmed as a direct target of miR-641. The of treatment of the PI3K agonist, 740Y-P, could abrogate the antioncogenic potentials of miR-641 in breast cancer cells. Conclusion. miR-641 functioned as a tumor suppressor through the PI3K/AKT signaling pathway via targeting NUCKS1 in breast cancer.

1 January 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
QSQianwen Shao
Qianwen Shao
JXJing Xu
Jing Xu
RDRong Deng
Rong Deng
WWWei Wei
Wei Wei
BZBing Zhou
Bing Zhou
HZHaitao Zhu
Haitao Zhu